Cookies and the protection of your data

We use cookies to improve the functionality of the website, to offer you a better website experience and to provide social media features. You give your consent by clicking on “Accept all Cookies” or as part of your individual settings. Please find detailed information on the use of cookies on this website in our Data Privacy Statement.

Functional Cookies

These cookies are necessary for the operation of the site and enable security-relevant functions. In addition, we determine whether you want to remain logged in and to make our services available to you when you change between this and other websites.

Statistical Cookies

These cookies are used for analyzing user behavior on our website with the aim of improving user navigation. All data collected is evaluated anonymously. Further information is available on our data protection site.

Marketing Cookies

These cookies are used to deliver relevant advertising or to limit how many times you see an ad. Marketing cookies can share that information with the advertiser (third-party cookies). The legal basis for the data processing is the consent of the user.

Cala Health kIQ
Cala Health kIQ
Cala Health kIQ
Cala Health kIQ
Cala Health kIQ
Cala Health kIQ
Cala Health kIQ
Cala Health kIQ
Cala Health kIQ
Cala Health kIQ
Cala Health kIQ
Cala Health kIQ
Cala Health kIQ
Cala Health kIQ
2024

Share:

Cala Health kIQ

On-demand FDA approved therapy for tremor relief

Millions of people live with essential tremor or Parkinson’s disease. The effects of these tremors are debilitating, interfering with quality of life, and the ability to undertake everyday activities that many of us take for granted. Treatment options for these conditions have historically been medications or even surgery. The Cala kIQ System is a sleek, empowering, accessibly-designed wearable that delivers powerful, non-pharmacologic, and non-invasive TAPS (Transcutaneous Afferent Patterned Stimulation) therapy on demand, to radically reduce tremors and improve daily living. It’s the only FDA-approved device of its kind.

Client / Manufacturer

Cala Health

San Mateo, US
Design

PA Consulting design team

San Francisco, US
Date of Launch
2023
Development Time
up to 24 Month
Target Regions
North America
Target Groups
Consumers / Users

RELATED PROJECTS